Clinical Research Directory

Inclusion Criteria: 1. Males or females ≥18 years of age at the time of informed consent. 2. Confirmed clinical and CLIA certified genetic diagnosis of RP (except subjects with AD-NR2E3 mutation) 3. Presence of photoreceptors as determined by spectral-domain optical coherence tomography (SD-OCT). Exclusion Criteria: 1. Subject lacks evidence of outer nuclear layer, i.e., containing the nuclei of the retinal photoreceptors as determined by SD- OCT. 2. Considered unsuitable for any reason that may either place the subject at increased risk during participation or interfere with the interpretation of the study outcomes by the Investigator, or the Sponsor after reviewing the subject medical history and condition. 3. Previous treatment with a gene-therapy or cell therapy product, excluding OCU400. 4. Previous treatment with any investigational drug or device within one year, excluding OCU400. 5. Any contraindications for subretinal injection. 6. Cataract surgery within 3 months. YAG capsulotomy within 1 month. Any other intraocular surgery within 6 months